IL218021A0 - Methods, primers, probes and kits useful for the detection of braf mutations - Google Patents

Methods, primers, probes and kits useful for the detection of braf mutations

Info

Publication number
IL218021A0
IL218021A0 IL218021A IL21802112A IL218021A0 IL 218021 A0 IL218021 A0 IL 218021A0 IL 218021 A IL218021 A IL 218021A IL 21802112 A IL21802112 A IL 21802112A IL 218021 A0 IL218021 A0 IL 218021A0
Authority
IL
Israel
Prior art keywords
primers
probes
detection
methods
kits useful
Prior art date
Application number
IL218021A
Other languages
English (en)
Original Assignee
Response Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Response Genetics Inc filed Critical Response Genetics Inc
Publication of IL218021A0 publication Critical patent/IL218021A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Paints Or Removers (AREA)
IL218021A 2009-08-11 2012-02-09 Methods, primers, probes and kits useful for the detection of braf mutations IL218021A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23305409P 2009-08-11 2009-08-11
US23707809P 2009-08-26 2009-08-26
US30179010P 2010-02-05 2010-02-05
PCT/US2010/044997 WO2011019704A2 (en) 2009-08-11 2010-08-10 Methods, primers, probes and kits useful for the detection of braf mutations

Publications (1)

Publication Number Publication Date
IL218021A0 true IL218021A0 (en) 2012-04-30

Family

ID=43586772

Family Applications (1)

Application Number Title Priority Date Filing Date
IL218021A IL218021A0 (en) 2009-08-11 2012-02-09 Methods, primers, probes and kits useful for the detection of braf mutations

Country Status (12)

Country Link
US (1) US20140248614A1 (enExample)
EP (1) EP2464751B1 (enExample)
JP (1) JP2013501523A (enExample)
KR (1) KR20120099630A (enExample)
CN (1) CN102575295B (enExample)
AR (1) AR077844A1 (enExample)
AU (1) AU2010282632A1 (enExample)
CA (1) CA2770716A1 (enExample)
IL (1) IL218021A0 (enExample)
NZ (1) NZ598166A (enExample)
TW (1) TW201111517A (enExample)
WO (1) WO2011019704A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6153758B2 (ja) * 2012-04-20 2017-06-28 アークレイ株式会社 多型検出用プローブ、多型検出方法、薬効判定方法及び多型検出用キット
US10077474B2 (en) 2012-05-29 2018-09-18 Abbott Molecular, Inc. Method of designing primers, method of detecting single nucleotide polymorphisms (SNPs), method of distinguishing SNPs, and related primers, detectable oligonucleotides, and kits
CN102816851A (zh) * 2012-08-29 2012-12-12 苏州旷远生物分子技术有限公司 用于检测braf基因v600e突变的引物、探针、试剂盒及方法
CN102876784B (zh) * 2012-09-13 2014-11-19 周宏灏 焦磷酸测序法检测B-raf基因多态性的试剂盒及方法
EP2711432A1 (en) * 2012-09-21 2014-03-26 Genomica S.A.U. Method for detection of BRAF and PI3K mutations
EP3473250B1 (en) 2012-12-27 2022-08-17 Quest Diagnostics Investments Incorporated Ddr2 mutations as targetable features of melanoma or basal cell carcinoma
CN103103269B (zh) * 2013-01-18 2015-07-15 陕西佰美基因股份有限公司 一种基于探针熔解技术准确检测braf基因突变的方法
JP2016512041A (ja) * 2013-03-15 2016-04-25 アボツト・モレキユラー・インコーポレイテツド 多重対立遺伝子の検出
KR101378920B1 (ko) * 2013-04-18 2014-03-27 주식회사 현일바이오 Ｂｒａｆ 돌연변이의 선택적 검출 방법 및 이를 이용한 키트
US20160108479A1 (en) * 2013-08-14 2016-04-21 Qiagen Mansfield, Inc. Compositions and methods for multiplex analysis of nras and braf nucleic acids
CN104017887A (zh) * 2014-06-18 2014-09-03 广州好芝生物科技有限公司 人类braf基因突变检测引物对和探针及其试剂盒
CA2954689A1 (en) * 2014-07-11 2016-01-14 Expression Pathology, Inc. Srm/mrm assay for the serine/threonine-protein kinase b-raf (braf)
CN105400900A (zh) * 2015-12-29 2016-03-16 杭州迪安生物技术有限公司 焦磷酸测序技术检测braf基因v600e微量突变试剂盒及其应用
CN105861691A (zh) * 2016-05-06 2016-08-17 北京晋祺生物科技有限公司 一种braf基因突变检测的引物组合物、试剂盒及方法
US12364776B2 (en) 2017-06-29 2025-07-22 Korea Advanced Institute Of Science And Technology Ganglioglioma-induced animal model and a method for diagnosing and treating ganglioglioma and related diseases
KR20190038464A (ko) * 2017-09-29 2019-04-08 (재)록원바이오융합연구재단 Ras/braf 돌연변이 검출용 조성물 및 이를 포함하는 키트
CN109161594A (zh) * 2018-08-17 2019-01-08 中山大学达安基因股份有限公司 一种检测braf基因突变的方法及其试剂盒
WO2022119423A1 (ko) * 2020-12-04 2022-06-09 주식회사 제노픽스 폐암 유전자 돌연변이 초고감도 선택적 증폭 방법 및 이를 위한 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004337120A (ja) * 2003-05-19 2004-12-02 Chang Gung Univ 膀胱癌再発検査方法
US7745125B2 (en) * 2004-06-28 2010-06-29 Roche Molecular Systems, Inc. 2′-terminator related pyrophosphorolysis activated polymerization
CN101487051B (zh) * 2009-02-24 2011-07-20 广州益善生物技术有限公司 Braf基因突变的检测探针、液相芯片及其检测方法

Also Published As

Publication number Publication date
WO2011019704A3 (en) 2011-07-07
CN102575295A (zh) 2012-07-11
EP2464751A4 (en) 2013-07-03
KR20120099630A (ko) 2012-09-11
AU2010282632A1 (en) 2012-03-08
AR077844A1 (es) 2011-09-28
NZ598166A (en) 2014-03-28
TW201111517A (en) 2011-04-01
EP2464751A2 (en) 2012-06-20
EP2464751B1 (en) 2017-05-24
CN102575295B (zh) 2016-02-17
JP2013501523A (ja) 2013-01-17
WO2011019704A2 (en) 2011-02-17
US20140248614A1 (en) 2014-09-04
CA2770716A1 (en) 2011-02-17
HK1172931A1 (zh) 2013-05-03

Similar Documents

Publication Publication Date Title
IL218021A0 (en) Methods, primers, probes and kits useful for the detection of braf mutations
SG173822A1 (en) Probes and primers for detection of chikungunya
EP2430446A4 (en) METHOD AND COMPOSITIONS FOR DETECTING ANALYTES
EP2179037A4 (en) DIAGNOSIS, FORECASTING AND TREATMENT PROCEDURES
GB0906458D0 (en) Macromolecules for diagnosis and prognosis
ZA201302022B (en) Nmr systems and methods for the detection of analytes
WO2011008262A9 (en) Methods and apparatus for diagnosis and/or prognosis of cancer
EP2348111A4 (en) PROBES FOR DETECTING kRAS GENE MUTATIONS, LIQUICHIP AND PROOF PROCESS THEREFOR
EP2406613A4 (en) METHOD AND SYSTEM FOR MEASURING / DETECTING CHEMICAL LEAVES
EP2600761A4 (en) MEMBRANE COMPOSITION FOR BIOSENSOR, BIOSENSOR AND METHODS OF MAKING THE SAME
BR112013012450A2 (pt) composições, métodos de detecção e kits
GB0915869D0 (en) Composition and assay method for the detection of patogenic bacteria
GB0905076D0 (en) Diagnostic kits and methods
EP2520660A4 (en) KITS FOR THE QUANTITATIVE DETECTION OF K-RAS MUTATIONS
EP2257648A4 (en) OPTIMIZED PROBES AND PRIMERS AND METHOD FOR THEIR USE TO DETECT AND QUANTIFY THE BK VIRUS
EP2540838A4 (en) KITS FOR THE QUANTITATIVE DETECTION OF BRAF MUTATIONS
EP2284262A4 (en) PRIMER AND PROBE FOR DETECTION OF MYCOBACTERIUM INTRACELLULARE, AND METHOD FOR DETECTION OF MYCOBACTERIUM INTRACELLULARE USING THE PRIMER OR PROBE
EP2495318A4 (en) PROBE FOR DETECTION OF POLYMORPHISM OF THE MPL GENE AND USE THEREOF
SG10201403780WA (en) Method and/or primers for the detection of mycobacterium tuberculosis
SG173803A1 (en) Probes and primers for detection of malaria
GB0806431D0 (en) Rapid detection of mycobacteria
IL210499A0 (en) Diagnostic methods and kits for detecting the development of jaw osteonecrosis
SG10201406505WA (en) Methods for the detection of fatty-acylated proteins
GB0820300D0 (en) Apparatus and method for the detection of cells
EP2518143A4 (en) PROBES FOR THE DETECTION OF C-kit GENE POLYMORPHISMS AND ASSOCIATED APPLICATIONS